Company profile

Mainstay Medical International specializes in manufacturing and marketing medical devices for the treatment of chronic, persistent or recurrent pain in the low back. The company provides a back muscle neurostimulation system allowing the restoring of spinal column in order to alleviate pain. Net sales break down geographically as follows: Ireland (16.4%), Germany (80.8%) and Europe (2.8%).

Source: Cofisem - Last Update: 16 Oct 2019
Key Executives
Chief Executive Officer Jason Hannon
Company Secretary Matthew Onaitis
Chief Financial Officer Matthew Onaitis
Investor Relations Brian Ritchie
Source: Cofisem - Last Update: 25 Apr 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 579 304
Income from ordinary activities 579 304
Operating income -25.603 -24.234 -14.712 -11.246 -13.254
Cost (net) of financial indebtedness -1.652 -1.689 -1.487 -236 -28
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -27.170 -26.084 -16.399 -11.571 -72.098
Net income (Group share) -27.170 -26.084 -16.399 -11.571 -72.098
Fiscal year end 12,18 12,17 12,16 12,15 12,14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 16 Oct 2019
Shareholder information
FCPR Sofinnova Capital VI 27,50 %
KCK 18,00 %
Fountain Healthcare Partners Fund 1 10,70 %
Ireland Strategic Investment Fund 8,10 %
Danny Sachs 5,90 %
Seamus Mulligan 4,20 %
Capricorn Health-Tech Fund NV 4,00 %
Perceptive Life Sciences Master Fund 3,70 %
Source: Cofisem - Last Update: 25 Apr 2019

Address

Mainstay Medical International

77 Sir John Rogersons Quay
IE-D02 VK60 Dublin 2
Ireland
Phone number: +353 (0)1 8970270
Fax: +353
Source: Cofisem - Last Update: 16 Oct 2019

Contact

Matt Onaitis
Phone number: +31 6 15 61 50 04
Source: Mainstay Medical International - Last Update: 16 Oct 2019